Altmann; Eva

Patent Applications and Registrations

Patent applications and USPTO patent grants for Altmann; Eva.The latest application filed is for "pyrrolidine derivatives and their use as complement pathway modulators".

Company Profile

0.13.16

Altmann; Eva - Reinach CH
Altmann; Eva - Basel N/A CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Complement pathway modulators and uses thereof Grant 9,815,819 - Altmann , et al. November 14, 2	2017-11-14
Complement pathway modulators and uses thereof Grant 9,487,483 - Altmann , et al. November 8, 2	2016-11-08
Pyrrolidine derivatives and their use as complement pathway modulators Grant 9,468,661 - Altmann , et al. October 18, 2	2016-10-18
Pyrrolidine derivatives and their use as complement pathway modulators Grant 9,388,199 - Altmann , et al. July 12, 2	2016-07-12
Complement pathway modulators and uses thereof Grant 9,085,555 - Altmann , et al. July 21, 2	2015-07-21
Pyrrolidine Derivatives And Their Use As Complement Pathway Modulators App 20150190457 - Altmann; Eva ; et al.	2015-07-09
Pyrrolidine Derivatives And Their Use As Complement Pathway Modulators App 20150166578 - Altmann; Eva ; et al.	2015-06-18
Complement Pathway Modulators And Uses Thereof App 20150148349 - Altmann; Eva ; et al.	2015-05-28
Complement Pathway Modulators And Uses Thereof App 20150141455 - Altmann; Eva ; et al.	2015-05-21
Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives Grant 8,569,317 - Altmann , et al. October 29, 2	2013-10-29
Complement pathway modulators and uses thereof App 20120295884 - ALTMANN; Eva ; et al.	2012-11-22
Heteroaryl nitrile derivatives Grant 7,820,818 - Altmann , et al. October 26, 2	2010-10-26
Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives Grant 7,696,216 - Altmann , et al. April 13, 2	2010-04-13
Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives App 20100063075 - Altmann; Eva ; et al.	2010-03-11
Heteroaryl Nitrile Derivatives App 20090227596 - Altmann; Eva ; et al.	2009-09-10
Hetereoaryl nitrile derivatives Grant 7,544,688 - Altmann , et al. June 9, 2	2009-06-09
Dipeptide Nitriles App 20080027060 - Altmann; Eva ; et al.	2008-01-31
Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases Grant 7,112,589 - Altmann , et al. September 26, 2	2006-09-26
Hetereoaryl nitrile derivatives App 20060142575 - Altmann; Eva ; et al.	2006-06-29
Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives App 20060079685 - Altmann; Eva ; et al.	2006-04-13
Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases App 20060074092 - Altmann; Eva ; et al.	2006-04-06
Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases App 20040249153 - Altmann, Eva ; et al.	2004-12-09
Dipeptide derivatives App 20040110806 - Altmann, Eva ; et al.	2004-06-10
Dipeptide nitriles App 20040029814 - Altmann, Eva ; et al.	2004-02-12
N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof Grant 6,051,577 - Altmann April 18, 2	2000-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.